Remove BioTech Remove Digital Health Remove Life Science Remove Pharmaceuticals
article thumbnail

Accelerator Life Science Partners Launches Biotechnology Startup Company in Singapore with $16M in Series A Commitments

Digital Health Global

Our mission is to accelerate the commercialization of breakthrough innovations like the AUTAC platform for health impact, and we welcome Automera and ALSP to Singapore’s growing life sciences translational community.” Together, we advance Singapore as a global life sciences translational hub.

article thumbnail

EVERSANA Completes Integration of Healthware Group and Strengthens Its Global Agency Network EVERSANA INTOUCH With Addition of New Full-Service Affiliate

Digital Health Global

EVERSANA INTOUCH Healthware joins five full-service affiliates and four specialty affiliates serving clients across the globe with world-class strategy, next-generation branding and creative, and innovative solutions to propel the future of life science marketing. They are, however, fully owned and operated by EVERSANA.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

EVERSANA Expands Global Commercialisation Capabilities and Strengthens Agency Network with Healthware Group Acquisition

Digital Health Global

The acquisition immediately expands EVERSANA’s European operations and worldwide capabilities to help pharmaceutical, medical device, and emerging biotech companies globally launch products, expand market access, or solve unique geographic and market-specific challenges. .

article thumbnail

Seamless Therapeutics Launches with $12.5M Seed Financing to Advance Transformative Gene Editing Platform Based on Programmable Precision Designer Recombinases

Digital Health Global

The seed round was co-led by Wellington Partners and Forbion and includes non-dilutive financing from BMBF GO-Bio, a prestigious German government initiative aimed at supporting the most innovative startups in the life sciences. Forbion invests in life sciences companies that are active in the (bio) pharmaceutical space.

article thumbnail

Tools for Paying Medical Bills Don’t Help Health Consumers Manage Their Financial Health

Health Populi

There’s a gap between the supply of digital health tools that hospitals and health systems offer patients, and what patients-as-consumers need for overall health and wellbeing. Nowhere in the top 10 most commonly provided digital tools is one for price transparency, cost comparing or cost estimating. .

article thumbnail

Emerging trends in the European HealthTech M&A market 2023

Lloyd Price

The key trends that are expected to shape the market in 2023 include: Increased focus on digital health: Healthcare companies are increasingly looking to acquire digital health businesses in order to improve their offerings and stay ahead of the competition. Engage with the HealthTech Community Thoughts, comments?

article thumbnail

Let’s Save the Date and Make Patient Engagement Official in 2022

Society for Participatory Medicine

Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. Market forces drove acceleration in digital health, specifically telemedicine, which were sorely needed for several years.

BioTech 107